Formulation Scientist for R&D of Ind Swift Ltd, Chandigarh

2 - 7 Years

Job Description

M. Pharma with 3-7 years of experience for formulation development of products for the regulated markets US/Europe etc.

These scientists should have experience in development of Immediate Release and Modified Release Products

Salary: Not Disclosed by Recruiter

Industry:Pharma / Biotech / Clinical Research

Functional Area:Medical, Healthcare, R&D, Pharmaceuticals, Biotechnology

Role Category:R&D

Role:Formulation Scientist

Employment Type:Permanent Job, Full Time


Desired Candidate Profile

Formulation Development of products for the regulated markets US/Europe etc.

Development of Immediate Release and Modified Release Products


UG:B.Pharma - Pharmacy

PG:M.Pharma - Pharmacy

Company Profile

Ind Swift Ltd.

Established in 1986, Ind-Swift is a research driven pharmaceutical group that produces world class finished dosage forms, active pharmaceutical ingredients, and intermediates. Over the years, it has moved forward aggressively, consistently winning new customers worldwide and making inroads into challenging new markets and regions.

Combining cutting edge innovation with dynamic marketing, Ind-Swift has already become a US$ 450 million entity. In fact, it is confidently eyeing the one billion dollar revenue mark by 2020.

The Group's multiple state-of-the-art production facilities, at home and abroad, meet stringent international norms -- including those of the USFDA, UK MHRA, and the WHO.

Ind-Swift Ltd, is listed on the Bombay Stock Exchange and the National Stock Exchange.

Its business successes apart, the group sees itself as a stakeholder in the service to humanity, offering quality pharmaceuticals that mitigate illness and suffering, and contribute to a healthier and better world.
View Contact Details+

Recruiter Name:Sachin Sharma

Contact Company:Ind Swift Ltd.



Send a Query

Please provide your email address

Please enter your query

Supported Formats: doc, docx, rtf, pdf Max file size: 2MB

Please agree to the terms and conditions to continue.